2024-03-29T09:01:16Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00016301
2022-12-15T03:47:53Z
453:456
471:537:538:1102
How Cirrhosis is Treated in Estimation of Traffic Compensation
交通事故の損害賠償における肝硬変症の賠償医学的検討
交通事故の損害賠償における肝硬変症の賠償医学的検討
佐々木, 匠
103953
liver cirrhosis
compensation medicine
traffic compensations
life expectancy
肝硬変
賠償医学
交通事故損害賠償
余命
This study of compensation medicine looks into eight cases of traffic compensations and examines the influence of liver cirrhosis upon their estimation. In the calculation of lost profits, cirrhosis is used as a reason to shorten the working life expectancy, or regarded as a factor to contribute to the death. So those eight cases are grouped into three types:I) “shortened working life expectancy”, II) “death contributory”, and III)“I-II combined”. The results of the ratable judgment of lost profits show that the way of type I or II is more advisable than that of type III in the estimation of compensation, for the twofold abatement of lost profits was made in type III. Among the four cases in which the working life expectancy was shortened, one carried out a valid estimation, using medical data properly, two cases misused it, and one showed no reason for its shortening. Valid estimation of traffic compensation requires proper understanding of cirrhosis including its convalescence estimation based on the latest medical achievements and survival rates. For this reason it is necessary to gather more of these cases and pursue the study of compensation medicine.
departmental bulletin paper
新潟医学会
1998-11
application/pdf
新潟医学会雑誌
11
112
693
702
新潟医学会雑誌
AN00182415
00290440
https://niigata-u.repo.nii.ac.jp/record/16301/files/112(11)_693-702.pdf
jpn